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AbstrACt
Objectives To demonstrate that urine cytology 
screening can provide relevant epidemiological data 
for earlier detection of urothelial cancer caused by 
occupational exposure.
Design Prospective cohort study.
setting Industries using urothelial carcinogens in 
France. Urine samples were collected on site, after 
a work week and were analysed at the University 
Hospital of Clermont-Ferrand, France.
Participants Participants were workers exposed to 
urothelial carcinogens. Women and current smokers 
at time of study recruitment were exclusion  
criteria.
Outcomes Urine cells atypia were ranged into 
three classes: negative/normal, atypical/suspicious/
dysplasia or positive/malignant.
results We included 2020 workers over a period of 
20 years from 1993 to 2013: 606 worked in rubber 
manufacturing, 692 from metal processing, 245 in 
chemical industry and 477 in roadwork and building 
industry. Workers had a mean exposure of 15.2±10.4 
years before their first urine cytology screening. There 
was a mean of 3.4±4.3 urine cytology screenings per 
worker between 1993 and 2013. 6478 cytology were 
normal, 462 suspicious and 13 malignant. Suspicious 
and malignant cytology occurred in 4.8% of workers 
exposed for 1–10 years, 6.2% for 11–20 years of 
exposure, 7.6% for 21–30 years and 8.6% for >30 
years (p<0.001). Using exposure for 1–10 years as 
reference, the adjusted OR of receiving a suspicious 
or malignant diagnosis increased with duration of 
exposure: OR=1.50 (95% CI 1.10 to 2.05, p=0.01) 
for 21–30 years and OR=1.78 (95% CI 1.23 to 2.56, 
p=0.002) for >30 years of exposure. Using metal 
processing as reference, the risk of pathological urine 
cytology results increased for rubber manufacturing 
(OR=1.32, 95% CI 1.05 to 1.65, p=0.02), with a trend 
for roadwork and building industry (OR=1.39, 95% CI 
0.98 to 1.97, p=0.07) and for chemical industry 
(OR=1.34, 95% CI 0.94 to 1.93, p=0.11).
Conclusions Urine cytology is a useful tool in 
occupational medicine. We promote new guidelines 
with an early screening of urothelial cancer by cytology, 
starting with beginning of exposure.
IntrODuCtIOn
Urinary tract cancers are a public health 
problem. With 11 965 new cases in 2012 in 
France and 386 000 worldwide in 2008, urothe-
lial bladder cancer is the seventh cancer world-
wide.1 2 In France, urothelial bladder cancer 
is the fifth most common cancer in men.3 
More generally, occupational exposure is a 
major cause of urinary tract cancer including 
kidney and bladder cancer.4 5 Among poten-
tial urothelial carcinogens existing, three 
classes are recognised: aromatic amines,6–10 
polycyclic aromatic hydrocarbons7 11 and 
nitrosamines.2 8 11–13 These carcinogens are 
mainly used in rubber manufacturing,7 10 13–15 
chemical industry,6 7 15 roadwork industry13 
and metal processing.13 16–19
Besides tobacco consumption, the propor-
tion of urothelial cancer due to occupational 
exposure ranges from 5% to 25%.2 20 21 In 
France, this proportion is largely underes-
timated: claims for recognition of occupa-
tional diseases are few.3 22 This is partly due 
to the very long latency between the first 
exposition and the diagnosis, from 14 to 
26 years and rarely before 20 years.2 22 The 
frequency and latency of urinary tract cancers 
offered a potential for large-scale screening 
in workers exposed to urothelial occupa-
tional carcinogens. Prognosis of urinary tract 
cancers is better when a diagnosis is made at 
an early stage.23 Earlier diagnosis is needed 
for survival improvement, in conjunction 
with aggressive radical surgery in intention 
strengths and limitations of this study
 ► We analysed a large-scale sample size of workers 
over a 20-year period.
 ► Our rigorous inclusion criteria avoided potential bias.
 ► We did not have final diagnosis or an eventual 
occupational disease recognition.
group.bmj.com on October 5, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Dutheil F, et al. BMJ Open 2017;7:e016238. doi:10.1136/bmjopen-2017-016238
Open Access 
to cure (cystectomy) and/or adjuvant multimodal treat-
ment (radiotherapy and chemotherapy).24 However, early 
stages are rarely detected, because clinical symptoms 
occur late in the evolution of the disease. Thus, screening 
during an early stage of urinary tract cancers appears 
salient. Actually, screening is based on urine cytology also 
called Papanicolaou cytology. Individuals with a positive 
cytology need a cystoscopy to make positive diagnosis. 
Whatever tumours’ grades and stages, urine cytology has 
a high specificity up to 90%. Sensitivity increases with 
severity of tumours, reaching excellent values for high-
grade tumours requiring urgent medical care.2 25–28
To the best of our knowledge, no studies provided 
results of large-scale screening for urothelial cancers in 
workers over consecutive decades. Despite duration of 
exposure increases incidence of urothelial cancers,2 no 
studies showed dose–response relationship based on a 
huge number of urine cytology. There are also no studies 
comparing urine cytology anomalies in main occupa-
tional sectors. Although the introduction of measures 
protecting workers over the last decades,2 12 17 29–33 urothe-
lial cancer remains frequent. There are several studies on 
amelioration of industrial hygiene and bladder cancer, 
but none or very few concerning all the urinary tract 
cancer.
Therefore, our hypothesis would be that (1) there are 
dose–response relationships—anomalies would increase 
with the duration of exposure; (2) urine cytology would 
differentiate at-risk occupational sectors such as rubber 
manufacturing, chemical industry, roadwork and building 
industry and metalworking; (3) urine cytology would 
demonstrate industrial hygiene improvements.
The aim of this study is to demonstrate that urine 
cytology screening can provide relevant epidemiological 
data for earlier detection of urothelial cancer caused by 
occupational exposure to urinary tract carcinogens, using 
a large-scale sample size of workers over a 20-year period.
MethODs
Participants
Participants were workers potentially exposed to 
urinary tract occupational carcinogens, in France and 
mainly in the Auvergne region. Follow-up was assessed 
by their occupational physician. Their occupational 
physician recorded sociodemographic and occupa-
tional data such as gender, birthdate, occupational 
sector, date of first and last occupational exposure and 
thus the duration of exposure. Occupational exposure 
could have started any time prior to the first screening 
provided by physicians (ie, before the beginning of 
the follow-up). Women and current smokers at time of 
study were excluded. We included 2020 workers over 
a period of 20 years, from 1993 to 2013. All included 
participants were men and non-smokers. Occupational 
sectors were rubber manufacturing for 606 workers, 
metal processing for 692 workers, chemical industry for 
245 workers and roadwork and building industry for 
477 workers. All rubber manufacturing workers were 
employed in the tyre sector. Metal processing workers 
included those within metalworking fluid and found-
ries. The chemical industry workers mainly included 
pharmaceutical manufacturers, who worked with dyes, 
adhesives or synthetic resins or in biological labora-
tories. Workers from roadwork and building industry 
were mainly exposed to asphalt and bitumen. The 
ethics committee from the University Hospital of Cler-
mont-Ferrand (CHU), France, concluded that there 
was no need for ethics approval when data collected for 
secondary analyses were unidentifiable and part of daily 
clinical practice (2015CE/101). Therefore, workers did 
not provide consent.
urine collection and analysis
Urine samples were collected on site, after several consec-
utive days of work. Urine samples were sent by post in 
refrigerated packages to the Center of Occupational 
Diseases of the University Hospital of Clermont-Ferrand 
(CHU), France. Urine samples were analysed within the 
24 hours after receipt date. High dysplasia and malignancy 
results were communicated directly to the occupational 
physician of workers for possible further investigations.
Outcomes: urine cytology classes
Based on Papanicolaou method, urine cells atypia were 
categorised in three classes34 35:
 ► Negative/normal: urothelial cells, sometimes irrita-
tive signs, no atypical or malignant signs.
 ► Atypical/suspicious/dysplasia: the cytological features 
were similar to those of malignancy but with a lesser 
degree. Nuclear enlargement was less prominent and 
nuclear cytoplasmic (N/C) ratios less disturbed.
 ► Positive/malignant: the cells showed features of high-
grade malignancy and were arranged both singly and 
in small, relatively flat sheets of up to 15 cells. Cell 
size was same or slightly larger than intermediate 
transitional cells with a shape round or polygonal, 
occasionally irregularly elongated. Nuclei were irreg-
ular in shape, notched or pointed. They were either 
vesicular or structureless. Nuclei were more than one 
and a half the size of normal nuclei with abnormal 
N/C ratios. Chromatin was black and structureless or 
coarse granular. Occasional cells contained multiple 
malignant nuclei. Nucleoli were generally absent or 
not prominent.
statistics
Statistics were computed with Stata V.13. Data are 
expressed as frequencies and associated percentages for 
categorical variables and as mean±SD and range or as 
median and IQR for quantitative parameters.
Univariate analysis of suspicious and malignant cytology 
was performed to test statistical relationships with age, 
duration of exposure, years of exposure, using χ2 trend 
test and using χ2 test when comparing with occupational 
sector. Multivariate analyses involved logistic regression, 
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adjusting for all these parameters. The odds ratio (OR) 
was calculated by dividing the odds of suspicious/malig-
nant cytologies versus the odds of normal cytologies. 
Results are showed as OR with their 95% CI. All tests were 
two-sided and a p value <0.05 was considered significant. 
For the age of workers, duration of exposure and years of 
exposure, data were both analysed as continuous variables 




Workers had a mean exposure of 15.2±10.4 years before 
their first urine cytology screening. There was a mean 
of 3.4±4.3 urine cytology screenings per worker between 
1993 and 2013. There were 6478 tests with normal 
cytology, 462 with dysplasia and 13 with malignant results. 
Therefore, 13 tests (0.19%) had criteria of urothelial 
cancer out of 6953 tests.
Dose–response relationship
There is a global dose–response relationship between 
duration of exposure and urine cytology classes. Suspi-
cious and malignant cytology accounted for 4.8% of 
workers exposed for 1–10 years, 6.2% for 11–20 years of 
exposure, 7.6% for 21–30 years and 8.6% for >30 years 
(p<0.001). Similarly, the severity of urine cytology classes 
increased with duration of exposure, comparing to an 
exposition of 1 to 10 years, within each occupational 
sectors: rubber manufacturing (4.3%, 7.5%, 9.1% and 
7.6% of suspicious and malignant cytology for expo-
sures of 1–10, 11–20, 21–30 and >30 years, respectively, 
p=0.005), metal processing (4.9%, 4.4%, 5.1% and 9% for 
exposures of 1–10, 11–20, 21–30 and >30 years, respec-
tively, p=0.004), with a trend for chemical industry (5.4%, 
5.3%, 9.1% and 9.3% for exposures of 1–10, 11–20, 21–30 
and >30 years, respectively, p=0.11) and roadwork and 
building industry (4.9%, 6.1%, 8% and 10.1% for expo-
sures of 1–10, 11–20, 21–30 and >30 years, respectively, 
p=0.06) (table 1 and figure 1).
Results were confirmed by multivariate analysis. With 
increasing duration of exposure the risk of showing a 
suspicious and malignant cytology increased linearly 
(OR=1.02, 95% CI 1.01 to 1.03, p<0.001) in the overall 
analysis, but only statistically significant in stratified anal-
ysis for workers from rubber manufacturing (OR=1.03, 
95% CI 1.01 to 1.04, p<0.001) (table 2). Similar signifi-
cant results were found using duration of exposure as a 
categorical variable (1–10, 11–20, 21–30 and >30 years). 
Using exposure during 1 to 10 years for comparative 
purposes, the odds of receiving a suspicious or malig-
nant diagnosis compared with a normal cytology was 
globally higher when duration of exposure increased: 
OR=1.50 for 21–30 years of exposure (95% CI 1.10 to 
2.05, p=0.01) and OR=1.78 for >30 years of exposure 
(95% CI 1.23 to 2.56, p=0.002). Results were similar 
Table 1 Urine cytology classes and duration of exposure
Negative Suspicious Malignant p Value
All occupational 
sectors
1–10 years, n (%) 1480 (95.2) 71 (4.6) 3 (0.2) 0.001
11–20 years, n (%) 1477 (93.8) 96 (6.1) 2 (0.1)
21–30 years, n (%) 2482 (92.3) 200 (7.4) 6 (0.2)
>30 years, n (%) 1039 (91.5) 95 (8.4) 2 (0.2)
Rubber manufacturing 1–10 years, n (%) 557 (95.7) 23 (4.0) 2 (0.3) 0.005
11–20 years, n (%) 685 (92.4) 55 (7.4) 1 (0.1)
21–30 years, n (%) 1300 (90.9) 126 (8.8) 4 (0.3)
>30 years, n (%) 380 (92.5) 29 (7.1) 2 (0.5)
Metal processing 1–10 years, n (%) 355 (95.2) 17 (4.6) 1 (0.3) 0.004
11–20 years, n (%) 436 (95.6) 20 (4.4) 0 (0)
21–30 years, n (%) 860 (94.9) 44 (4.9) 2 (0.2)
>30 years, n (%) 548 (91.0) 54 (9.0) 0 (0)
Chemical industry 1–10 years, n (%) 278 (94.6) 16 (5.4) 0 (0) 0.110
11–20 years, n (%) 143 (94.7) 8 (5.3) 0 (0)
21–30 years,  n (%) 150 (90.9) 15 (9.1) 0 (0)
>30 years, n (%) 49 (90.7) 5 (9.3) 0 (0)
Roadwork/building 
industry
1–10 years, n (%) 290 (95.1) 15 (4.9) 0 (0) 0.060
11–20 years, n (%) 213 (93.8) 13 (5.7) 1 (0.4)
21–30 years, n (%) 172 (92.0) 15 (8.0) 0 (0)
>30 years, n (%) 62 (89.9) 7 (10.1) 0 (0)
p values from χ2 tests.
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for rubber manufacturing: OR=1.79 for 11–20 years of 
exposure (95% CI 1.09 to 2.93, p=0.02), OR=2.24 for 
21–30 years of exposure (95% CI 1.39 to 3.59, p=0.001) 
and OR=1.99 for >30 years of exposure (95% CI 1.11 to 
3.57, p=0.02). Results were also not significant for metal 
processing chemical industry and for roadwork and 
building industry (table 3).
suspicious and malignant cytology and occupational 
sectors
Considering metal processing as reference with continuous 
variables for age, duration of exposure and years of expo-
sure, the risk of pathological urine cytology results increased 
for rubber manufacturing (OR=1.3, 95% CI 1.04 to 1.63, 
p=0.02) and for roadwork and building industry (OR=1.42, 
95% CI 1.00 to 2.01, p=0.05) (table 2). With categorised vari-
ables, results are similar for rubber manufacturing (OR=1.32, 
95% CI 1.05 to 1.65, p=0.02), with a trend for roadwork and 
building industry (OR=1.39, 95% CI 0.98 to 1.97, p=0.07) 
and for chemical industry (OR=1.47, 95% CI 0.94 to 1.93, 
p=0.11) (table 3 and figure 2).
Pathological urine cytology and age
With increasing age the risk of showing a suspicious and 
malignant cytology increased linearly (OR=1.02, 95% CI 
1.00 to 1.04, p=0.03) in the overall analysis, but only statis-
tically significant in stratified analysis for workers from 
chemical industry (OR=1.05, 95% CI 1.01 to 1.10, p=0.02) 
(table 2). Similarly, workers aged over 50 years old had 
a greater risk of suspicious and malignant cytology diag-
noses for chemical industry (OR=4.40, 95% CI 1.59 to 
12.14, p=0.004), with also a global trend (OR=1.38, 
95% CI 0.95 to 2.00, p=0.09). Results were not significant 
for other occupational sectors (table 3).
Pathological urine cytology and industrial hygiene 
improvements
The risk of showing a suspicious and malignant cytology 
decreased linearly with more recent years of exposure 
(OR=0.97, 95% CI 0.96 to 0.99, p=0.01) in the overall 
analysis, but only statistically significant in stratified anal-
ysis for workers from rubber manufacturing (OR=0.97, 
95% CI 0.94 to 0.99, p=0.02) (table 2). Similar significant 
Figure 1 Percentage of abnormal urine cytology (suspicious+malignant) and duration of exposure.
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results were found using years of exposure as a categorical 
variable. Suspicious and malignant cytology diagnoses 
globally decreased between 1993 and 2013. Using the 
1993–1997 period for comparative purposes, OR=0.73 
for the 1998–2002 period, (95% CI 0.58 to 0.92, p=0.006), 
OR=0.72 for 2003–2007 (95% CI 0.54 to 0.96, p=0.02), 
OR=0.67 for 2007–2013 (95% CI 0.49 to 0.91, p=0.01). 
Results were similar for metal processing: OR=0.55 for 
1998–2002 (95% CI 0.35 to 0.86, p=0.01) and OR=0.51 for 
2007–2013 (95% CI 0.28 to 0.93, p=0.03); for roadwork and 
building industry: OR=0.41 for 1998–2002 (95% CI 017 to 
0.98, p=0.04) and OR=0.30 for 2003–2007 (95% CI 0.09 
to 0.95, p=0.04) and for rubber manufacturing: OR=0.62 
for 2003–2007 (95% CI 0.40 to 0.97, p=0.04). Results were 
not significant for chemical industry (table 3).
DIsCussIOn
The major findings of this study were that urine cytology 
screening can provide relevant epidemiological data for 
earlier detection of urothelial cancer caused by occu-
pational exposure to urinary tract carcinogens, using a 
large-scale sample size of workers over a 20-year period. 
Specifically, we demonstrated that anomalies on urine 
cytology followed a dose–response relationship. Occupa-
tional sectors with an increased risk were rubber manu-
facturing, roadwork and building industry. Furthermore, 
industrial hygiene improvements permitted a reduction 
of anomalies on cytology.
urine cytology and occupational exposure: effectiveness and 
dose–response relationship
We reported a large sample of workers involved in 
a long-term follow-up of urinary tract occupational 
exposure with urine cytology. Previous literature 
generally completed investigations by cystoscopic 
examinations25 26 or compared different screening 
procedures.25 26 28 However, we demonstrated that urine 
cytology was a reliable tool to assess occupational expo-
sure to urinary tract carcinogens and provided relevant 
epidemiological data. As expected and showed for other 
carcinogens, age is a risk factor of cancer.36 Indeed in 
the majority of cases, urothelial tumours appear after 
Table 2 Multivariate analyses of risk for urine cytology anomalies in relations with occupational sectors and dose–response 
relationships by analysing the variables continuously
Continuous variables* OR 95% CI p Value
All occupational sectors
  Duration of exposure 1.02 1.01 to 1.03 <0.001
  Age 1.02 1.00 to 1.04 0.030
  Occupational sector Metal processing Reference
Rubber manufacturing 1.30 1.04 to 1.63 0.020
Chemical industry 1.37 0.95 to 1.96 0.090
Roadwork and building industry 1.42 1.00 to 2.01 0.050
  Years of exposure 0.97 0.96 to 0.99 0.010
Rubber manufacturing
Duration of exposure 1.03 1.01 to 1.04 <0.001
Age 1.00 0.97 to 1.02 0.800
Years of exposure 0.97 0.94 to 0.99 0.020
Metal processing
Duration of exposure 1.02 0.99 to 1.04 0.140
Age 1.03 0.99 to 1.06 0.130
Years of exposure 0.98 0.95 to 1.02 0.270
Chemical industry
Duration of exposure 1.01 0.98 to 1.04 0.680
Age 1.05 1.01 to 1.10 0.020
Years of exposure 1.00 0.94 to 1.06 0.890
Roadwork and building industry
Duration of exposure 1.02 0.98 to 1.06 0.330
Age 1.03 0.99 to 1.07 0.180
Years of exposure 0.97 0.92 to 1.01 0.150
Significant results (p<0.05) are highlighted in bold.
*Except for occupational sector.
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Table 3 Multivariate analyses of risk for urine cytology anomalies in relations with occupational sectors and duration of 
exposure, age and years of exposure as categorical variables
Categories OR 95% CI p Value
All occupational sectors
  Duration of exposure (years) 1–10 Reference
11–20 1.24 0.90 to 1.71 0.190
21–30 1.50 1.10 to 2.05 0.010
>30 1.78 1.23 to 2.56 0.002
  Age (years) <30 Reference
30–50 1.14 0.80 to 1.64 0.460
>50 1.38 0.95 to 2.00 0.090
  Occupational sector Metal processing Ref
Rubber manufacturing 1.32 1.05 to 1.65 0.020
Chemical industry 1.34 0.94 to 1.93 0.110
Roadwork/building industry 1.39 0.98 to 1.97 0.070
  Years of exposure 1993–1997 Ref
1998–2002 0.73 0.58 to 0.91 0.006
2003–2007 0.72 0.54 to 0.96 0.020
2007–2013 0.67 0.49 to 0.91 0.010
Rubber manufacturing
  Duration of exposure (years) 1–10 Reference
11–20 1.79 1.09 to 2.93 0.020
21–30 2.24 1.39 to 3.59 0.001
>30 1.99 1.11 to 3.57 0.020
  Age <30 Reference
30–50 0.69 0.37 to 1.28 0.240
>50 0.74 0.40 to 1.38 0.350
  Years of exposure 1993–1997 Reference
1998–2002 0.83 0.61 to 1.13 0.250
2003–2007 0.62 0.40 to 0.97 0.040
2007–2013 0.75 0.47 to 1.19 0.220
Metal processing
  Duration of exposure (years) 1–10 Reference
11–20 0.86 0.44 to 1.66 0.650
21–30 0.96 0.50 to 1.84 0.900
>30 1.60 0.80 to 3.21 0.180
  Age <30 Reference
30–50 1.11 0.59 to 2.09 0.750
>50 1.32 0.66 to 2.63 0.440
  Years of exposure 1993–1997 Reference
1998–2002 0.55 0.35 to 0.86 0.010
2003–2007 0.97 0.61 to 1.54 0.900
2007–2013 0.51 0.28 to 0.93 0.030
Chemical industry
  Duration of exposure (year) 1–10 Reference
11–20 0.77 0.31 to 1.92 0.570
21–30 1.05 0.47 to 2.33 0.900
>30 0.92 0.30 to 2.81 0.880
Continued
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the age of 60 years.36 37 Participants older than 50 were 
more likely to have a malignant or suspicious cytology. 
We further found a globally increased RR of receiving 
a suspicious or malignant diagnosis with duration of 
exposure, in agreement with recommendations to 
screen workers exposed to urothelial carcinogens 20 
years after the beginning of occupational exposure.2 
However, the dose–response relationship appeared 
significant from 10 years of exposure, especially for 
rubber manufacturing. Moreover, from experience, 
we noted that early screening was associated with best 
prognosis and industrial hygiene improvements. There-
fore, we strengthen the evidence for new guidelines 
supporting an early screening of urinary tract cancer, 
starting from the beginning of occupational exposures. 
Because of the high latency period between exposure 
and cancer, and because the significant relationship 
between age and the risk of abnormal urine cytology, 
we propose to extend screening beyond retirement 
(postprofessional follow-up). Both strategies should be 
Categories OR 95% CI p Value
  Age <30 Reference
30–50 2.02 0.72 to 5.66 0.180
>50 4.40 1.59 to 12.14 0.004
  Years of exposure 1993–1997 Reference
1998–2002 1.40 0.66 to 2.99 0.390
2003–2007 0.89 0.31 to 2.55 0.830
2007–2013 0.84 0.31 to 2.29 0.740
Roadwork/building industry
  Duration of exposure (years) 1–10 Reference
11–20 0.92 0.41 to 2.09 0.840
21–30 1.14 0.47 to 2.78 0.770
>30 1.34 0.43 to 4.15 0.620
  Age (years) <30 Reference
30–50 1.53 0.63 to 3.70 0.350
>50 1.62 0.64 to 4.12 0.310
  Years of exposure 1993–1997 Reference
1998–2002 0.41 0.17 to 0.98 0.040
2003–2007 0.30 0.09 to 0.95 0.040
2007–2013 0.55 0.27 to 1.12 0.100
Significant results (p<0.05) are highlighted in bold.
Table 3 Continued 
Figure 2 Percentage of suspicious and malignant cytology in each occupational sector. *p<0.05.
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further evaluated, including the best interval between 
two consecutive urine cytology screenings.
Occupational sectors
Among potential urothelial carcinogens existing, three 
classes were recognised: aromatic amines6 (such as benzi-
dine,7 aniline, o-tolidine, o-toluidine,8 9 10 beta naph-
tylamine7), polycyclic aromatic hydrocarbons (such 
as benzene,12 13 38 benz(a)pyrene11) and nitrosamines 
(such as nitrobenzene8). They were used in various occu-
pational sectors such as rubber manufacturing,7 10 13–15 
chemical and pharmaceutical industry,7 dye manu-
facturing,6 7 15 textile,15 plastic, leather and tanning 
industry, roadwork industry,13 metalworkers,16 metal-
working fluids,17 18 aluminium,19 foundries.13 19 Recom-
mendations for medical follow-up of workers exposed to 
urinary tract carcinogens classified occupational sectors 
in four levels of risk, from low to very high. Very high-
risk occupational sectors were rubber manufacturing 
and dye manufacturing. High-risk occupational sectors 
were aluminium production, textile industry, leather 
and tanning industry, plastics industry using chloroan-
iline and production of 4-chloro-ortho-toluidine-based 
pesticides. Occupational sectors with a moderate risk 
were chemical and pharmaceutical industry, iron and 
steel foundries, metalworking.2 Therefore, our study 
confirmed the increased risk of urothelial cancer for 
those working in the rubber manufacturing2 15 which 
combines several urinary tract carcinogens such as 
o-toluidine, aniline and nitrobenzene.8 However, we 
also demonstrated the highest increased risk for road-
work and building industry which is not recognised by 
the current recommendations.2 Thus, we also promote 
to screen roadwork and building industry workers with 
urine cytology.
Industrial hygiene improvements
Since the first occupational bladder cancer discovered in 
1895 in a German dye factory manufacturing fuchsin,31 32 
advances had been made concerning industrial hygiene. 
In 1974, the Occupational Safety and Health Administra-
tion promulgated a standard to control the production 
and use of benzidine.31 In Great Britain, beta-naphtyl-
amine were removed in 1949.33 In France, three aromatic 
amines (benzidine, beta-naphtylamine, 4-amino-bi-
phenyle) were prohibited in 1989. A decrease of the inci-
dence after introduction of measures protecting workers 
(substitution, modification of process, protection equip-
ment) was observed.29 30 We confirmed those industrial 
hygiene improvements, especially in metal processing, 
roadwork and building industry. Nevertheless, addressing 
issues of industrial hygiene is still a public health concern 
at work.12 17 For example, aromatic amines were prohib-
ited in France, but many other carcinogens still persist 
such as o-tolidine, o-toluidine, o-anisidine, chloroaniline 
(4,4-methylenebis(2-chloroaniline)), and secondary 
amines reacting with nitrosamines.2
limitations
There are a number of limitations to this study. Diversified 
occupational exposure to various potential carcinogens 
may appear as a limitation, but our classification provided 
significant insight into occupational sectors and should 
not preclude generalisability. Moreover, we did not assess 
other urothelial cancer risk factors. However, we included 
the main risk factors that account for more than 80% 
of urothelial cancer.39 There were only a few case with 
malignant cytology, nevertheless the huge sample size of 
workers allowed an adequate statistical power to support 
the primary hypothesis. Despite we did not include 
women and smokers, our rigorous inclusion criteria 
avoided potential bias. The 1990s could appear recent 
regarding improvements in occupational hygiene, though 
the 20-year period of screening provided informative 
data for public health management at work. We empha-
sise the lack of reference test and limitations of urine 
cytology. Although different techniques were reported to 
enhance sensitivity and specificity in detection of urothe-
lial tumours such as UroVision, immunocytochemistry or 
markers as NMP22, their high cost and poor availability 
are not compatible with a first grade screening.2 26 28 40 
Moreover, the use of a single screening tool, that is, urine 
cytology permitted comparisons over time. We did not 
have final diagnosis or a possible occupational disease 
recognition. However, our study may contribute to an 
earlier detection of occupational urothelial cancer and 
might improve primary prevention at workplaces.2 41 
Giving the low cost of urine cytology and the absence of 
data collection risks (non-irradiant, non-invasive, pain-
less, easy to collect and easy to measure), cost-effective 
studies should demonstrate its benefits. The number 
of cases saved from urothelial cancer death because of 
abnormal urine cytology should also be further investi-
gated. Despite the significant relationship between age 
and the risk of abnormal cytology, the absence of results 
beyond retirement may have underestimated the effects 
of age, giving the latency of the disease. Screening after 
retirement should be further evaluated.
COnClusIOns
Urine cytology screening can provide relevant epidemi-
ological data for earlier detection of urothelial cancer 
caused by to occupational exposure to urinary tract 
carcinogens. Occupational sectors with an increased risk 
of urothelial cancer are rubber manufacturing, roadwork 
and building industry. Relative risk of receiving a suspi-
cious or malignant diagnosis increased with duration of 
exposure, in agreement with recommendations to screen 
workers exposed to urothelial carcinogens 20 years after 
the beginning of occupational exposure. However, we 
demonstrated a significant linear dose–response rela-
tionship between duration of exposure and detection 
of a suspicious or malignant cytology. As early screening 
was associated with best prognosis and industrial hygiene 
improvements, we strengthen the evidence to support 
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new guidelines for an early screening of urinary tract 
cancer by urine cytology screening, starting with initial 
exposure, reassessed during years of working life and 
extended after retirement (postprofessional follow-up).
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